Cite
The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
MLA
Zou, Renrui, et al. “The Identification of N6-Methyladenosine-Related MiRNAs Predictive of Hepatocellular Carcinoma Prognosis and Immunotherapy Efficacy.” Cancer Biomarkers, vol. 38, no. 4, Apr. 2023, pp. 551–66. EBSCOhost, https://doi.org/10.3233/CBM-230263.
APA
Zou, R., Liu, Y., Qiu, S., Lu, Y., Chen, Y., Yu, H., Zhu, H., Zhu, W., Zhu, L., Feng, J., & Han, J. (2023). The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy. Cancer Biomarkers, 38(4), 551–566. https://doi.org/10.3233/CBM-230263
Chicago
Zou, Renrui, Yaqian Liu, Sangsang Qiu, Ya Lu, Yan Chen, Hui Yu, Hangju Zhu, et al. 2023. “The Identification of N6-Methyladenosine-Related MiRNAs Predictive of Hepatocellular Carcinoma Prognosis and Immunotherapy Efficacy.” Cancer Biomarkers 38 (4): 551–66. doi:10.3233/CBM-230263.